Anti-insulin-like growth factor-IIP3 DNAzymes inhibit cell proliferation and induce caspase-dependent apoptosis in human hepatocarcinoma cell lines

References

• El-Serag HB Hepatocellular carcinoma N Engl J Med 2011 365 12 1118 1127 21992124
   PubMed Web of Science ®Google Scholar
• Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No 10 Lyon, France International Agency for Research on Cancer Available from: http://globocan.iarc.fr Accessed May 12, 2013
   Google Scholar
• Cabibbo G Latteri F Antonucci M Craxi A Multimodal approaches to the treatment of hepatocellular carcinoma Nat Clin Pract Gastroenterol Hepatol 2009 6 3 159 169 19190599
   PubMedGoogle Scholar
• Marrero JA Kudo M Bronowicki JP The challenge of prognosis and staging for hepatocellular carcinoma Oncologist 2010 15 Suppl 4 23 33 21115578
   PubMed Web of Science ®Google Scholar
• Chen PJ Furuse J Han KH Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts’ opinion Liver Int 2010 30 10 1427 1438 20557456
   PubMed Web of Science ®Google Scholar
• Wilhelm SM Adnane L Newell P Villanueva A Llovet JM Lynch M Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling Mol Cancer Ther 2008 7 10 3129 3140 18852116
   PubMed Web of Science ®Google Scholar
• Pollak M Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 2008 8 12 915 928 19029956
   PubMed Web of Science ®Google Scholar
• Breuhahn K Longerich T Schirmacher P Dysregulation of growth factor signaling in human hepatocellular carcinoma Oncogene 2006 25 27 3787 3800 16799620
   PubMed Web of Science ®Google Scholar
• Breuhahn K Schirmacher P Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma World J Gastroenterol 2008 14 11 1690 1698 18350600
   PubMed Web of Science ®Google Scholar
• Brissenden JE Ullrich A Francke U Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor Nature 1984 310 5980 781 784 6382023
   PubMed Web of Science ®Google Scholar
• Chao W D’Amore PA IGF2: epigenetic regulation and role in development and disease Cytokine Growth Factor Rev 2008 19 2 111 120 18308616
   PubMed Web of Science ®Google Scholar
• Qian B Katsaros D Lu L IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics Oncol Rep 2011 25 1 203 213 21109978
   PubMed Web of Science ®Google Scholar
• Vernucci M Cerrato F Besnard N The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis Oncogene 2000 19 54 6376 6385 11175353
   PubMed Web of Science ®Google Scholar
• Uchida K Kondo M Takeda S Osada H Takahashi T Nakao A Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma Mol Carcinog 1997 18 4 193 198 9142213
   PubMed Web of Science ®Google Scholar
• McManus SA Li Y The structural diversity of deoxyribozymes Molecules 2010 15 9 6269 6284 20877222
   PubMed Web of Science ®Google Scholar
• Schlosser K Li Y Biologically inspired synthetic enzymes made from DNA Chem Biol 2009 16 3 311 322 19318212
   PubMedGoogle Scholar
• He J Zhang D Wang Q Wei X Cheng M Liu K A novel strategy of chemical modification for rate enhancement of 10–23 DNAzyme: a combination of A9 position and 8-aza-7-deaza-2′-deoxyadenosine analogs Org Biomol Chem 2011 9 16 5728 5736 21717014
   PubMed Web of Science ®Google Scholar
• Wang F Elbaz J Orbach R Magen N Willner I Amplified analysis of DNA by the autonomous assembly of polymers consisting of DNAzyme wires J Am Chem Soc 2011 133 43 17149 17151 21954996
   PubMed Web of Science ®Google Scholar
• Teng B Xin D Wen L Cui S Jin C Research of 10–23 DNAZyme inhibit the expression of eIF4E genes Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007 21 12 552 554 Chinese 17802829
   PubMedGoogle Scholar
• Verma N Tripathi SK Chaudhury I Das HR Das RH iNOS-targeted 10–23 DNAzyme reduces LPS-induced systemic inflammation and mortality in mice Shock 2010 33 5 493 499 19823115
   PubMed Web of Science ®Google Scholar
• Wang TH Li WT Yu SH Au LC The use of 10–23 DNAzyme to selectively destroy the allele of mRNA with a unique purine-pyrimidine dinucleotide Oligonucleotides 2008 18 3 295 299 18699741
   PubMedGoogle Scholar
• Kong DM Xu J Shen HX Positive effects of ATP on G-quadruplex-hemin DNAzyme-mediated reactions Anal Chem 2010 82 14 6148 6153 20552961
   PubMed Web of Science ®Google Scholar
• Zhang M Zhao H Luo F Luo S Shi W IGF-II inhibitory DNAzymes inhibit the invasion and migration of hepatocarcinoma cells Biotechnol Lett 2011 33 5 911 917 21267763
   PubMed Web of Science ®Google Scholar
• Dass CR Tan ML Galloway SJ Choong PF Dz13 induces a cytotoxic stress response with upregulation of E2F1 in tumor cells metastasizing to or from bone Oligonucleotides 2010 20 2 79 91 20406096
   PubMedGoogle Scholar
• Yu SH Wang TH Au LC Specific repression of mutant K-RAS by 10–23 DNAzyme: sensitizing cancer cell to anti-cancer therapies Biochem Biophys Res Commun 2009 378 2 230 234 19014906
   PubMed Web of Science ®Google Scholar
• Mosmann T Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 1983 65 1–2 55 63 6606682
   PubMed Web of Science ®Google Scholar
• Zhou H Tang Y Liang X RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo Int J Cancer 2009 125 2 453 462 19391133
   PubMed Web of Science ®Google Scholar
• Crawford ED Wells JA Caspase substrates and cellular remodeling Annu Rev Biochem 2011 80 1055 1087 21456965
   PubMed Web of Science ®Google Scholar
• Riedl SJ Salvesen GS The apoptosome: signalling platform of cell death Nat Rev Mol Cell Biol 2007 8 5 405 413 17377525
   PubMed Web of Science ®Google Scholar
• Taylor RC Cullen SP Martin SJ Apoptosis: controlled demolition at the cellular level Nat Rev Mol Cell Biol 2008 9 3 231 241 18073771
   PubMed Web of Science ®Google Scholar
• Liu GN Teng YX Yan W Transfected synthetic DNA enzyme gene specifically inhibits Egr-1 gene expression and reduces neointimal hyperplasia following balloon injury in rats Int J Cardiol 2008 129 1 118 124 18242730
   PubMed Web of Science ®Google Scholar
• Zhou J Yang XQ Xie YY Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice Virus Res 2007 130 1–2 241 248 17804108
   PubMed Web of Science ®Google Scholar
• Hallett MA Teng B Hasegawa H Schwab LP Seagroves TN Pourmotabbed T Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer Breast Cancer Res 2013 15 1 R12 23407024
   PubMed Web of Science ®Google Scholar
• Kosman J Juskowiak B Peroxidase-mimicking DNAzymes for biosensing applications: a review Anal Chim Acta 2011 707 1–2 7 17 22027115
   PubMed Web of Science ®Google Scholar
• Qiu LW Yao DF Zong L Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development Hepatobiliary Pancreat Dis Int 2008 7 4 406 411 18693177
   PubMed Web of Science ®Google Scholar
• Rockwell P O’Connor WJ King K Goldstein NI Zhang LM Stein CA Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides Proc Natl Acad Sci U S A 1997 94 12 6523 6528 9177251
   PubMed Web of Science ®Google Scholar
• Wahlestedt C Salmi P Good L Potent and nontoxic antisense oligonucleotides containing locked nucleic acids Proc Natl Acad Sci U S A 2000 97 10 5633 5638 10805816
   PubMed Web of Science ®Google Scholar
• Fluiter K ten Asbroek AL de Wissel MB In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides Nucleic Acids Res 2003 31 3 953 962 12560491
   PubMed Web of Science ®Google Scholar
• Dass CR Galloway SJ Choong PF Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation Oligonucleotides 2010 20 3 137 146 20180631
   PubMedGoogle Scholar
• Wu Y Yu L McMahon R Rossi JJ Forman SJ Snyder DS Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes) Hum Gene Ther 1999 10 17 2847 2857 10584930
   PubMed Web of Science ®Google Scholar
• Liang Z Wei S Guan J DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells J Gastroenterol Hepatol 2005 20 10 1595 1602 16174080
   PubMed Web of Science ®Google Scholar
• Tang SH Yang DH Huang W Zhou HK Lu XH Ye G Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population Clin Cancer Res 2006 12 14 Pt 1 4171 4177 16857788
   PubMed Web of Science ®Google Scholar
• Kiss A Wang NJ Xie JP Thorgeirsson SS Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met, TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas Clin Cancer Res 1997 3 7 1059 1066 9815784
   PubMed Web of Science ®Google Scholar
• Merle P de la Monte S Kim M Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma Gastroenterolog y 2004 127 4 1110 1122
   Web of Science ®Google Scholar
• Veronese A Lupini L Consiglio J Oncogenic role of miR-483-3p at the IGF2/483 locus Cancer Res 2010 70 8 3140 3149 20388800
   PubMed Web of Science ®Google Scholar
• Callegari E Elamin BK Giannone F Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model Hepatology 2012 56 3 1025 1033 22473819
   PubMed Web of Science ®Google Scholar